Senores Pharmaceuticals lists with 52% premium on the BSE

30 Dec 2024 Evaluate

Senores Pharmaceuticals has debuted at Rs 593.70 on the BSE, up by 202.7 points or 51.84% from its issue price of Rs 391.00. 

The scrip is currently trading at Rs 569.25, up by 178.25 points or 45.59% from its issue price. 

It has touched a high and low of Rs 609.00 and Rs 566.85 respectively. So far 6.74 lakh shares were traded on the counter.

The offering, which was open for subscription between December 20, 2024 and December 24, 2024 was subscribed around 93 times. The issue price was fixed at Rs 391.00 per share i.e. at upper end of price band of Rs 372-391apiece.

Senores Pharmaceuticals is global research driven pharmaceutical company engaged in developing and manufacturing a wide range of generic pharmaceutical products in the B2B segment predominantly for the Regulated Markets across various therapeutic areas and dosage forms.

Senores Pharmaceutic Share Price

777.40 -6.85 (-0.87%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×